We previously showed that a percutaneous arteriovenous gas exchanger was effective in removing CO 2 and reversing respiratory failure in an ovine model of adult respiratory distress syndrome (ARDS) produced by smoke inhalation and burn injury (Alpard et al., Ann Surg 230:215-224, 1999). In this study, we tested the hypothesis that arteriovenous CO 2 removal (AVCO 2 R) lessened endogenous inflammation in the lung. Myeloperoxidase activity, aquaporin-1 (AQP-1), interleukin-8 (IL-8), and inducible nitric oxide synthase mRNAs as well as aquaporin-1, and IL-8 protein were measured in ovine lung tissue. Lung tissue was taken at 96 h (time of sacrifice) from animals with combined smoke inhalation and 40% third degree dermal burn and subsequently treated with AVCO 2 R or sham (ventilator alone) after onset of ARDS (PaO 2 :FiO 2 ratio of < 200). Myeloperoxidase activity was 1.862 ؎ 0.302 U/mg protein in the ventilator group and 0.830 ؎ 0.141 in the AVCO 2 R plus ventilator group. AQP-1 mRNA was 140,482 ؎ 31,702 copies/g total RNA in the ventilator group and 61,854 ؎ 22,433 copies/g total RNA in the AVCO 2 R plus ventilator group (p ‫؍‬ 0.076). mRNA for IL-8 mRNA in the ventilator alone treated animals was 74,000 ؎ 3,300 copies/g total RNA compared to < 1,000 copies/g total RNA in the ventilator plus AVCO 2 R group. This result was highly significant (p < 0.001) Inducible nitric oxide synthase mRNA was 7,853 ؎ 2,229 copies/g total RNA for the AVCO 2 R group and 5,854 ؎ 2,070 copies/g total RNA for the ventilator managed animals. These differences were not statistically significant (p ‫؍‬ 0.54). Percutaneous AVCO 2 R produced a specific decrease in IL-8 in the smoke and burn injured animals. Furthermore, this effect was consistent with cell signaling mechanisms that increase the expression of IL-8 by cyclic stretching and the observed reduction in the number of neutrophils in the lung parenchyma. Therefore, we speculate that the mechanism by which CO 2 removal exerts a beneficial effect may be due to both decreases in ventilatory requirements, with an accompanying reduction in alveolar stretching, and reduction of neutrophil numbers in lung tissue.
Morbidity and mortality from smoke inhalation, combined with dermal burn, exceeds either injury alone and presents with a 30 -80% mortality. 1, 2 The resultant systemic insult has many characteristics of adult respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS). 3, 4 These include a heterogeneous distribution of inflammation and edema in the lung, as well as a characteristic decrease in lung compliance. 5 We have recently developed an LD 40 sheep model of combined smoke inhalation and dermal burn injury 6 that closely reproduces the natural history of similar lesions in humans. These animals develop criteria consistent with ARDS (PaO 2 /FiO 2 Ͻ 200) within 48 h. At that time, the animals are placed on an arteriovenous (A-V) percutaneous CO 2 removal device (AVCO 2 R) to remove 95-98% of CO 2 production and allow decreased minute ventilation and peak airway pressures. The animals receiving the device consistently recover, while 40% of the animals receiving only ventilator management succumb. 6 In this study, we examined the hypothesis that endogenous lung inflammation is lessened in those animals receiving AVCO 2 R. Interleukin-8 (IL-8) mRNA was greatly reduced in those animals with AVCO 2 R treatment compared with those treated with standard ventilator management alone.
Materials and Methods

Animals
Animals were cared for in the Ovine Intensive Care Unit at our institution, which is approved by the American Association of Laboratory Animal Care. The experimental procedures were approved by the Animal Care and Use Committee of the University of Texas Medical Branch. Guidelines for care and use of animals from the National Institutes of Health and American Physiological Society were strictly followed. Animals were studied in the awake state.
Our model of severe respiratory failure secondary to combined smoke inhalation and cutaneous flame burn injury was previously described. 6 Approximately 80% of these animals reach criteria for ARDS. For this study, adult Suffolk ewes that met criteria for ARDS (n ϭ 10) (~35-45 kg) were allocated to two groups of five animals each (group 1, ventilator alone; group 2, AVCO 2 R plus ventilator). All animals had right femoral artery and vein catheters and a pulmonary artery/thermal dilution cardiac output catheter (Baxter Edwards Critical-Care, Irvine, CA) placed at least 48 h before injury.
In preparation for the smoke/burn injury, the animals received a tracheostomy and a Shiley, low-pressure cuffed tra-cheostomy tube (size 10) (Shiley 8DCT, Mallinckrodt Medical TPI, Irvine, CA) that was connected to a volume controlled ventilator (Servo 900C, Siemens-Elema, Solna, Sweden). The injury was produced by 36 breaths of cotton smoke and a 40% total body surface area (TBSA) full-thickness flame burn to the flanks (20% TBSA for each flank) of the animal. The animals were resuscitated with lactated Ringer's solution according to the Parkland formula. 7 Minute ventilation and FiO 2 were adjusted to maintain arterial pH at 7.35-7.45, PaCO 2 Ͻ 40 mm Hg, and PaO 2 Ͼ 60 mm Hg.
Animals were randomized to ventilator alone or ventilator plus AVCO 2 R when the PaO 2 /FiO 2 reached Ͻ 200 (generally at~48 h after injury). Animals not achieving ARDS criteria were excluded from the study and are not included in the statistical analysis. Animals reaching entry criteria were reanesthetized, administered 300 IU/kg of bovine lung heparin (Upjohn, Kalamazoo, MI), and started on antibiotic therapy (ampicillin, 1 g; gentamicin, 80 mg/ml). Animals randomized to AVCO 2 R had the left carotid artery cannulated (percutaneous 10 -12F TF018LH, Research Medical, Midvale, UT) and the left internal jugular vein cannulated (percutaneous, 14 -16F TF022L, Research Medical) as previously described. 8 A low resistance membrane gas exchanger (Affinity, Avecor Cardiovascular, Plymouth, MN) was primed with normal saline (270 ml) and connected to the vascular cannulas after deairing. This gas exchanger had a surface area of 2.4 m 2 , and a flow rate of 950 -1,100 ml/min was maintained. Pure oxygen was used as a sweep gas. Activated clotting time (Hemochron 400, International Technidyne, Edison, NH) was maintained between 300 and 500 seconds with a continuous heparin infusion throughout the study. After initiation of AVCO 2 R flow with extracorporeal CO 2 removal, mechanical ventilation was reduced in a stepwise fashion according to our ventilator management algorithm. 8 Initial reductions were made in tidal volume (TV; 20% reduction) to reduce the positive inspiratory pressure below 30 cm H 2 O. Once targeted airway pressures were achieved, RR was incrementally reduced to allow a longer respiratory cycle and gentle inspiratory flow. Further reductions in TV were made until the TV reached the estimated dead space volume (2-3 ml/kg), provided that arterial blood gases could be maintained at or above target levels. Concurrently, FiO 2 was reduced as long as PaO 2 remained greater than 60 mm Hg. Positive end expiratory pressure was kept at 5 cm H 2 O throughout the study.
mRNA Isolation
Lung tissue from animals at 96 h after smoke/burn injury (48 h after initiation of AVCOR or sham) was excised at the time of killing and immersed in liquid nitrogen. Total RNA was obtained using a commercially available total RNA purification kit, Purescript (Gentra Systems, Inc., Minneapolis, MN). Briefly, 100 mg of the freshly frozen lung tissue was lysed and homogenized using a mortar and pestle with 3 ml of lysis buffer containing EDTA, citric acid, and sodium dodecyl sulfate (SDS) according to the manufacturer's protocol. Precipitation buffer was then added and incubated for 10 min on ice to precipitate protein and DNA and centrifuged at 3,000 g. The supernatant was placed in 3 ml of isopropanol and centrifuged at 3,000 g for 5 minutes. The pellet was washed with 3 ml of 70% ethanol, centrifuged again, and air-dried for 10 minutes. The pellet was resuspended in DEPC treated water. Total RNA was quantitated spectrophotometrically at 260 nm. mRNA was isolated from total RNA by the Straight A's mRNA Isolation System (Novagen, Madison, WI) purification procedure in which mRNA is first hybridized to oligo-dT coupled magnetic beads, washed, and then eluted to obtain polyadenylated mRNA according to the manufacturer's protocol.
Preparation of Sheep Lung cDNA
First strand cDNA was synthesized by reverse transcription of the mRNA samples obtained using MMLV derived reverse transcriptase (Perkin Elmer, Branchburg, NJ) and random hexamers for priming according to standard procedures. 9 The cDNA was then used as a template for quantitative PCR.
Quantitative PCR of Aquaporin-1, IL-8, and Inducible Nitric Oxide Synthase cDNA Competitive internal standards based on sequences from the v-erB gene were used to quantitate the resulting aquaporin-1 (AQP-1), IL-8, and inducible nitric oxide synthase (iNOS) cDNA. Fragments of this gene were constructed to contain 5' and 3' ends that were identical to the corresponding primers utilized for amplification of the aquaporin-1, IL-8, and iNOS ( Table 1) .
Initially, 10-fold dilutions of the competitive cDNA template (v-erB gene sequence) were mixed with a constant amount of sample cDNA and subjected to amplification using a final concentration of 2 mM MgCl 2 , 0.375 U of Taq polymerase Table 1 
. Primers for cDNA Amplification
Primer
Sequence Product Size   IL-8 sense  5Ј-TCT AGA ACG AGA GCC AGA AG-3Ј  IL-8 antisense  5Ј-ATC GAG GCA CAG TTG AAC AG-3Ј  737  IL-8 (AmpliTaq, Perkin-Elmer) and 0.2 mM dTPs in a reaction volume of 15 l. The mixture was amplified for 35 cycles at a melting temperature of 94°C for 1 minute (6 minutes on first cycle), an annealing temperature of 57°C for 1 min, and extension at 72°C, for 1 min (7 min on final cycle). The amplification products were electrophoresed on a 1% agarose gel containing ethidium bromide. After an approximate equivalence point was ascertained from the 10-fold dilutions, two-fold dilutions were made for more accurate determination of equivalence points.
Western Blotting for Aquaporin-1
Sheep lung tissue was homogenized with a tissue grinder, sonicated twice for 30 s, and then solubilized with 1% IGEPAL CA-630 in phosphate buffered saline (PBS). Ten to 20 g of this tissue was subjected to SDS-polyacrylamide gel electrophoresis on 12% gels. 10 The separated proteins were transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH) using a Bio-Rad transblot apparatus (Bio-Rad, Hercules, CA). The filters were treated with 5% skim milk in Tris-PBS for 1 h and then incubated overnight at room temperature with a rabbit polyclonal (AQP-1) antibody (L266, a generous gift from Dr. Mark Knepper, NIH) (1:1,500 dilution, in 1% skim milk, 005% Tween-20, and Tris-buffered saline, pH 74) that crossreacts with sheep aquaporin-1. 10, 11 After washing, the filters were developed with affinity purified horseradish peroxidase conjugated goat anti-rabbit immunoglobulin G (IgG; 1:1,000 dilution in the above buffer). After washing, visualization of the bands was accomplished by addition of enhanced chemiluminescence reagents to the filters (Amersham, Piscataway, NJ) and exposing them to Hyperfilm MP film (Amersham, Arlington Heights, IL) for 1 to 5 minutes. The resulting radiographs were scanned, and relative densities of the bands were determined by densitometry using Sigma Gel software (SPSS, Inc, Chicago, IL). Western blotting of iNOS was attempted.
Enzyme Linked Immunosorbent Assay for IL-8
Lung tissue was homogenized and sonicated as described for Western blotting. Detection of IL-8 in the homogenates was accomplished with a sandwich enzyme linked immunosorbent assay (ELISA) consisting of K221, a human monoclonal antibody that cross-reacts with sheep IL-8 12 as the capture antibody and goat polyclonal anti-human IL-8 (R&D Systems, Minneapolis, MN) as the second antibody. The sandwich was detected by HRP conjugated donkey anti-goat IgG (Jackson Laboratories). The lower detection limit for this assay was approximately 20 pg/ml.
Myeloperoxidase Activity
For measurement of myeloperoxidase (MPO), lung tissue (200 -300 mg) from the left lung was processed immediately and suspended in 5 volumes (w/v) of 0.5% hexadecyltrimethyl ammonium bromide in 50 mM phosphate buffer, pH 6.0. The tissue was homogenized for 45 seconds and then sonicated on ice for 60 seconds. After centrifugation at 9000 g, the supernatant was collected, and the lung tissue cell pellet was reextracted for a total of four extractions. 23 The supernatants were combined for measurement of MPO and protein. Supernatant was then assayed spectrophotometrically by the method of Krawisz et al. using o-dianisidine and H 2 O 2 . 24 One unit of MPO is defined as that degrading 1 mol of peroxide per minute at 25°C. Protein in lung tissue and neutrophils was measured using a bicinchoninic acid protein assay kit (Pierce).
Statistical Analysis
Comparisons between AVCO 2 R plus ventilator treated animals and control animals treated with the ventilator alone were assessed by two tailed t-tests using a commercial statistical package (SigmaStat, version 2, Jandel Scientific Software, San Rafael, CA). All data met the criteria for normality and equal variance. PaO 2 values between treatment groups were analyzed using analysis of variance (ANOVA) for a balanced, two-factor experiment with repeated measures on time. The two factors were experimental groups (ventilator, and AVCO 2 R plus ventilator treated injury groups) and time. Multiple comparisons were made when the ANOVA indicated there were statistically significant differences among the groups to identify the origin of the significant differences. A Tukey correction procedure was used for the multiple comparisons.
Results
PaO 2 /FiO 2 Ratios in Smoke and Burn Injured Sheep
PaO 2 /FiO 2 ratios were significantly improved in the AVCO 2 R treated animals compared with those treated with ventilator management alone (p Ͻ 0.05) (Figure 1) . This improvement began within a few hours after beginning AVCO 2 R. At 60 h after injury, tidal volumes in the AVCO 2 R treated animals were 89 Ϯ 15 ml/kg compared with 145 Ϯ 13 ml/kg in the ventilator alone managed animals (p Ͻ 0.05). Similarly, the respiratory rate necessary to maintain normal PaCO 2 in the AVCO 2 R treated animals was 16.8 Ϯ 4 per minute compared AQP-1, IL-8, and iNOS mRNA mRNA was quantitatively determined on sheep lungs sacrificed 48 h after reaching the PaO 2 /FiO 2 criteria of 200. AQP-1 mRNA was 140,482 Ϯ 31,702 copies/g total RNA in the ventilator group and 61,854 Ϯ 22,433 copies/g total RNA in the AVCO 2 R plus ventilator group (p ϭ 0.076) (Figure 2) . In contrast, mRNA for IL-8 in the ventilator alone treated animals was 74,000 Ϯ 3,300 copies/g total RNA compared with Ͻ 1,000 copies/g total RNA in the ventilator plus AVCO 2 R group (Figure 3) ; this result was highly significant (p Ͻ 0.001). Finally, iNOS mRNA was 7,853 Ϯ 2,229 copies/g total RNA for the AVCO 2 R group and 5,854 Ϯ 2,070 for the ventilator managed animals (Figure 4) . These differences were not statistically significant (p ϭ 0.54).
Western Blotting for AQP-1
Concentrations of AQP-1 in lung tissue were compared for the two groups. In the AVCO 2 R plus ventilator treated animals the concentration was 7,888 Ϯ 1,336 optical density units (pixels/mg lung tissue), whereas that for the ventilator alone treated animals was 8,903 Ϯ 2,198 optical density units (pixels/mg lung tissue) (Figure 5 ). There were no significant differences in these means (p ϭ 0.753). We were unable to detect iNOS by Western blotting because the amounts of this enzyme were below the detection limits of our system.
ELISA for IL-8
Concentrations of IL-8 in lung tissue were 288 Ϯ 178 pg/mg lung tissue for the AVCO 2 R treated group and 777 Ϯ 129 pg/mg lung tissue for the ventilator alone managed animals (p ϭ 0.10) (Figure 6 ). Although these values were lower for the AVCO 2 R treated animals compared with the ventilator alone treated group, consistent with the findings of mRNA for IL-8, the concentrations of this chemokine were low, making the results less certain.
Myeloperoxidase Activity
Myeloperoxidase activity measured at the time of sacrifice in ventilator treated or AVCO 2 R plus ventilator treated animals The mean concentration for iNOS mRNA in the AVCO 2 R treated group was somewhat lower than that found for the ventilator alone group, but the difference was not statistically significant (p ϭ 0.54).
was significantly lower in the latter group (p ϭ 0.012). Myeloperoxidase activity was 1.862 Ϯ 0.302 U/mg protein in the ventilator group and 0.830 Ϯ 0.141 U/mg protein in the AVCO 2 R plus ventilator group (Figure 7) .
Discussion
The main finding of this study is that both IL-8 mRNA and protein are decreased in smoke and burn injured animals treated with percutaneous A-V CO 2 removal. This effect ap-pears to be specific in that no difference was noted for iNOS mRNA, less difference was found for AQP-1 mRNA, and no difference was found for AQP-1 protein between the two treatment groups. The purpose of this study was to begin investigation of the mechanism of benefit of percutaneous CO 2 removal. IL-8 was chosen as a variable because it is produced both by lung epithelial cells and inflammatory cells, 13 and it is an important mediator of acute lung injury. 14, 15 Inducible NOS was chosen for similar reasons and the differences in control of its expression from those governing IL-8. AQP-1 mRNA was of interest because it is remarkably increased after smoke and burn injury in sheep (manuscript submitted for publication), and it is chiefly produced not by lung parenchyma or inflammatory cells but by microvascular endothelium. 16 We considered possibilities that the improvement produced by percutaneous A-V CO 2 removal was due to improved CO 2 homeostasis, differences in hemodynamic and pulmonary mechanics, decreased numbers of emigrating neutrophils, differences in nitric oxide production, removal of mediators by the AVCO 2 R device, and less lung injury associated with barotrauma and volutrauma. Use of the device without sweep gas to remove the CO 2 is ineffective, making the proposition of removal of mediators by the polypropylene membrane unlikely (data not shown). The finding that IL-8 is remarkably decreased in the AVCO 2 R treated animals compared with the animals treated with ventilator management alone suggests that the endogenous inflammation associated with ARDS may be partially and specifically reduced by percutaneous CO 2 removal. One possibility was that the influx of neutrophils into the lung parenchyma was reduced in the AVCO 2 R treated animals. Neutrophil numbers, as estimated by MPO activity in the lung parenchyma of AVCO 2 R plus ventilator treated animals, were reduced by approximately one-half compared with ventilator treated animals. Because neutrophils can produce substantial amounts of IL-8, it is possible that the decrease in neutrophil numbers accounts for some of the decrease in amount of IL-8 found in the lung parenchyma of the AVCO 2 R treated animals. However, neutrophils can also produce substantial amounts of iNOS (and perhaps neural NOS) mRNA. 17, 18 If the decrease in neutrophil numbers were the sole explanation of the decreased amount of IL-8 in AVCO 2 R, it is likely that iNOS mRNA would be decreased as well; this was not observed. The specific effect on IL-8 by AVCO 2 R treatment is also consistent with a reduction of ventilator induced inflammation. Recent work with in vitro cell cultures showed that cyclic stretching of A549 cells (derived from type II alveolar epithelial cells) resulted in substantial increase in the amount of IL-8 secreted by these cells, while secretion of granulocyte-macrophage colony stimulating factor and tumor necrosis factor-␣ (TNF-␣) are unaffected. 19 Furthermore, this effect was increased by the amplitude of the stretch but not the rate of cycling. In another study, A549 cells were again shown to produce IL-8 in response to cyclic stretching. 20 In their study, the three prototypic representatives of the mitogen activated protein kinase (MAPK) subfamilies (c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK), p38, and extracellular signal-regulated kinase (ERK) were examined for their role in IL-8 production. JNK/SAPK and p38 were involved in the increased transcription of IL-8, whereas ERK/2 was not. It is further interesting that Chan et al. 21 found that TNF-␣ and interferon-␥ induced up-regulation of iNOS in mouse macrophages possibly requires JNK/SAPK but not p38 or ERK. However, this same group found that IL-4 strongly inhibits TNF-␣ induced transcription of iNOS in mouse macrophages, but only modestly inhibits JNK/SAPK, suggesting that other signaling pathways besides JNK/SAPK may be involved in up-regulation of iNOS transcription. 22 Regulation of both IL-8 and iNOS expression is complex and dependent upon stimulus and cell type. Collectively, nevertheless, these data are consistent with effects of cyclic stretch on MAPK and the subsequent up-regulation of IL-8 transcription but with less effect on iNOS.
Conventional volume controlled ventilation causes iatrogenic injury to the lungs by inflicting barotrauma and volutrauma to both injured and noninjured portions of the lung. 23 The heterogeneity of lung compliance inflicts high peak pressures to the small fraction of remaining compliant alveoli and further exacerbates lung injury. Recent trends in ventilator management limit inflation pressures and tidal volumes, often at the cost of increased systemic arterial CO 2 concentration (permissive hypercapnia). 24 Lung protective strategies with permissive hypercapnia, however, may be limited in usefulness by the obligatory respiratory acidosis, which causes substantial changes in hemodynamics, organ blood flow, and intracranial pressure unless arterial blood pH is controlled. 25 Recently available, low-resistance oxygenators have been developed that minimize the foreign surface interactions and facilitate CO 2 removal. 26, 27 We coupled such a gas exchanger with percutaneous arterial and venous cannulas selected for the flow ranges necessary for total CO 2 removal for the treatment of respiratory failure. 28 AVCO 2 R was accomplished in this study with a simple A-V shunt with a low resistance gas exchange device for near total CO 2 removal. This technique avoided hypercapnia or the complex circuitry and monitoring required for extracorporeal membrane oxygenation. 26 -30 The animals treated with AVCO 2 R had significantly reduced tidal volumes and respiratory rates compared with the animals treated with ventilatory management alone, similar to animals studied in a previous trial. 6 Therefore, we speculate that the decrease in IL-8 and beneficial effect of percutaneous A-V CO 2 removal may be secondary to both reduction in ventilator trauma allowed by this treatment and reduction in neutrophil numbers in injured lung parenchyma.
